Vol 5 (12 Issues in 2016)
Edited by: Qingyi Wei, M.D., Ph.D.
Online ISSN: 2045-7634
Impact Factor: 2.5
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of cutting-edge research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery
Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach
Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
We aim to be a truly global forum for high-quality cancer research, and we think that the best research should be published and made widely accessible as quickly as possible. Cancer Medicine publishes papers submitted directly to the journal and those referred from a select group of prestigious journals published by Wiley-Blackwell. List available here.
Cancer Medicine is a Wiley Open Access journal, one of a new series of peer reviewed titles publishing quality research with speed and efficiency. For further information visit the Wiley Open Access website.
Open Access and Copyright
All articles published by Cancer Medicine are fully open access: immediately freely available to read, download and share. All Cancer Medicine articles are published under the terms of the Creative Commons Attribution License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Copyright on any research article in a journal published by Cancer Medicine is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. Further information about open access license and copyright can be found here.
Peer review policy
Cancer Medicine maintains the highest standards of peer review while increasing the efficiency of the process. All research articles published in the journal will undergo full peer review, and we pursue editorial approaches that may help us avoid bias. We will do our utmost to judge research objectively on its own merits and to avoid favoring research, for example, from particular institutions, countries, or regions. Key characteristics of the journal’s review process are:
• All research articles submitted directly to the Journal are initially evaluated by the Editor-in-Chief; articles found appropriate for the Journal will be reviewed by at least two suitably qualified experts.
• All manuscripts submitted directly to Cancer Medicine will be subject to double-blind peer review.
• Most submissions transferred to Cancer Medicine from partnering journals will be assessed using the original peer-review reports from those journals; however, the Editor-in-Chief will critically review these peer-review reports and may choose to send manuscripts out for additional double-blind review.
• All publication decisions are made by the Editor-in-Chief on the basis of the reviews provided.
• Members of the editorial board lend insight, advice and guidance to the Editor-in-Chief generally and assist in decision making on specific submissions.
• The managing editor and editorial assistant provide administrative support to ensure Cancer Medicine maintains the integrity of peer review and delivers rapid and efficient publication to authors and reviewers.
In addition to papers submitted directly to the journal, Cancer Medicine will also consider papers referred from other Wiley-Blackwell journals that are participating in the Manuscript Transfer Program. As part of our commitment to speed of publication, and in order to reduce strain on the peer-review system, we have set-up a mechanism to allow a select group of prestigious partner journals to refer high-quality manuscripts to Cancer Medicine, along with any existing peer-review reports, when these journals are not themselves able to accommodate the manuscripts (for example, on grounds of scope or space). For such manuscripts that have existing peer-review reports, our Editor-in-Chief is able to decide whether or not a manuscript is suitable for publication particularly quickly.
Abstracting and indexing information
Cancer Medicine will deposit all articles into PubMed Central upon publication of an online issue. Once your article is deposited in PubMed Central, they will make it searchable on PubMed as soon as possible. The journal will be pursuing application for other appropriate abstract and indexing services to ensure wide visibility of articles published in Cancer Medicine.